REFERENCES
- Edwards A O, Ritter R, 3rd, Abel K J, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308(5720)421–424
- Haines J L, Hauser M A, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308(5720)419–421
- Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38(9)1055–1059
- Hageman G S, Hancox L S, Taiber A J, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications. Ann Med 2006; 38(8)592–604
- Trouw L A, Seelen M A, Daha M R. Complement and renal disease. Mol Immunol 2003; 40(2–4)125–134
- Seelen M A, Daha M R. The role of complement in autoimmune renal disease. Autoimmunity 2006; 39(5)411–415
- Thompson C L, Klein B E, Klein R, et al. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. Hum Mol Genet 2007; 16(17)2135–2148
- Mullins R F, Aptsiauri N, Hageman G S. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis. Eye 2001; 15: 390–395, (Pt 3)
- Nitsch D, Douglas I, Smeeth L, Fletcher A. Age-Related Macular Degeneration and Complement Activation-Related Diseases: A population-based case-control study. Ophthalmology 2008; 115(11)1904–1910
- Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: The POLA Study. Ophthalmic Epidemiol 2001; 8(4)237–249
- Klein R, Klein B E, Linton K L, DeMets D L. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol 1993; 137(2)190–200
- Tomany S C, Wang J J, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology 2004; 111(7)1280–1287
- Evans J R, Fletcher A E, Wormald R P. 28,000 Cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005; 89(5)550–553
- Hallan S I, Dahl K, Oien C M, et al. Screening strategies for chronic kidney disease in the general population: Follow-up of cross sectional health survey. BMJ 2006; 333(7577)1047
- Liew G, Mitchell P, Wong T Y, Iyengar S K, Wang J J. CKD increases the risk of age-related macular degeneration. J Am Soc Nephrol 2008; 19(4)806–811
- Vassalotti J A, Stevens L A, Levey A S. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50(2)169–180
- Fletcher A E, Jones D A, Bulpitt C J, Tulloch A J, The M RC. Trial of Assessment and Management of Older People in the Community: Objectives, design and interventions [ISRCTN23494848]. BMC Health Serv Res 2002; 2(1)21
- Fletcher A E, Price G M, Ng E S, et al. Population-based multidimensional assessment of older people in UK general practice: A cluster-randomized factorial trial. Lancet 2004; 364(9446)1667–1677
- Rose G MP, Reid D D. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977; 31(1)42–48
- Evans J R, Fletcher A E, Wormald R P. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: An add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 2004; 111(3)513–517
- Evans J R, Fletcher A E, Wormald R P. Causes of visual impairment in people aged 75 years and older in Britain: An add-on study to the MRC Trial of Assessment and Management of Older People in the Community. Br J Ophthalmol 2004; 88(3)365–370
- Roderick P, Atkins R, Smeeth L, et al. Detecting chronic kidney disease in older people; What are the implications?. Age Ageing 2008; 37(2)179–186
- Klag M J, Whelton P K, Randall B L, et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277(16)1293–1298
- Timmerman J J, van der Woude F J, van Gijlswijk-Janssen D J, et al. Differential expression of complement components in human fetal and adult kidneys. Kidney Int 1996; 49(3)730–740
- van Kooten C, Langers A M, Bruijn J A, Daha M R. Role of tubular cells in progressive renal disease. Kidney Blood Press Res 1999; 22(1–2)53–61
- Murthy K, Stevens L A, Stark P C, Levey A S. Variation in the serum creatinine assay calibration:A practical application to glomerular filtration rate estimation. Kidney Int 2005; 68(4)1884–1887
- Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16(3)763–773
- Konta T, Hao Z, Takasaki S, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol 2007; 11(1)51–55
- Verhave J C, Hillege H L, Burgerhof J G, et al. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 2003; 14(5)1330–1335